Overview

Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of a reward devaluation strategy, which has been researched in the past, combined/augmented with the medication d-cycloserine in assisting smokers to switch from combustible cigarette (CC) to Juul.
Phase:
Phase 2
Details
Lead Sponsor:
Rose Research Center, LLC
Collaborator:
Foundation for a Smoke Free World INC
Treatments:
Cycloserine